KOAN — Apollo Biowellness Cashflow Statement
0.000.00%
Last trade - 00:00- $1.23m
- $5.37m
- $1.90m
- 62
- 55
- 45
- 54
Annual cashflow statement for Apollo Biowellness, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.94 | -5.76 | 0.654 | -1.42 | -2.13 |
| Depreciation | |||||
| Non-Cash Items | 0.77 | 3.18 | -2.27 | 0.772 | 0.342 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.21 | -0.379 | 0.178 | 0.646 | 0.745 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.38 | -2.95 | -1.43 | 0.011 | -1.03 |
| Capital Expenditures | — | -0.036 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | -0.805 | -0.358 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.036 | 0 | -0.805 | -0.358 |
| Financing Cash Flow Items | 1.01 | 1.38 | 0.091 | -0.085 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.49 | 2.88 | 1.48 | 0.736 | 1.39 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.111 | -0.101 | 0.052 | -0.057 | 0.001 |